Kobayashi Pharmaceutical Co., Ltd.
4967.T

$2.78 B
Marketcap
$37.46
Share price
Country
$-0.78
Change (1 day)
$46.79
Year High
$31.19
Year Low

Kobayashi Pharmaceutical Co., Ltd., together with its subsidiaries, manufactures and sells consumer products in Japan and internationally. The company provides products in the areas of healthcare, skincare, body warmer, and household. It also offers Ammeltz, a topical analgesic; Inochi no Haha, a women's health medicine; Shirt Coola, a summer cooling spray for cloths; Sarasaty lingerie soap; Bluelet Decoral, a toilet bowl cleaner and freshener; Nightmin Nasal Respiration Tape; Naishitol, a Chinese medicine; Eaude Muge, a medicated lotion for preventing acne; Itoyoji, a dental floss pick; BreathCare, an oral breath freshener capsule; Eybon, an eye wash; Netsusama sheet, a cooling gel sheet for forehead; and Sawaday, a toilet air freshener. Additionally, the company manufactures and sells pharmaceuticals, quasi-drugs, cosmetics, hygiene and paper products, health foods, and processed synthetic resin products; markets nutritional supplements and skin care products through sales promotional campaigns, such as advertising and direct mail; and sells skincare products, health foods, and other items through e-commerce channels. Further, it engages in transportation, real estate management, and advertising planning and production businesses. Kobayashi Pharmaceutical Co., Ltd. was founded in 1886 and is headquartered in Osaka, Japan.

marketcap

Earnings for Kobayashi Pharmaceutical Co., Ltd. (4967.T)

Earnings in 2023 (TTM): $182.89 M

According to Kobayashi Pharmaceutical Co., Ltd.'s latest financial reports the company's current earnings (TTM) are $182.89 M. The earnings displayed on this page is the company's Pretax Income.

Earnings history of Kobayashi Pharmaceutical Co., Ltd.

Annual Earnings

Year Income Before Tax Net Income
2023 $182.89 M $134.97 M
2022 $185.49 M $132.87 M
2021 $183.4 M $130.84 M
2020 $176.76 M $127.45 M
2019 $177.88 M $127.01 M
2018 $167.93 M $119.61 M
2017 $149.8 M $105.27 M
2016 $175.22 M $126.72 M
2015 $124.47 M $89.37 M
2014 $133.1 M $82.61 M
2013 $130.51 M $81.67 M
2012 $125.12 M $80.8 M
2011 $131.55 M $77.82 M
2010 $87.45 M $61.95 M
2009 $96.58 M $61.38 M
2008 $107.97 M $58.75 M
2007 $104.86 M $56.44 M
2006 $106.43 M $55.06 M
2005 $92.97 M $49.6 M
2004 $84.74 M $44.66 M